• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3D基因组工程:人类疾病的当前进展与治疗机遇

3D Genome Engineering: Current Advances and Therapeutic Opportunities in Human Diseases.

作者信息

Jiang Xing, Wang Xiaoli, Shen Song, Hou Shangguo, Yu Chen

机构信息

School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, China.

Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, China.

出版信息

Research (Wash D C). 2025 Sep 1;8:0865. doi: 10.34133/research.0865. eCollection 2025.

DOI:10.34133/research.0865
PMID:40901634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12399806/
Abstract

Dynamic chromatin 3-dimensional (3D) conformation is a key mechanism regulating gene expression and cellular function during development and disease. Elucidating the structure, functional dynamics, and spatiotemporal organization of the 3D genome requires integrating multiple experimental approaches, including chromatin conformation capture techniques, precise genome manipulation tools, and advanced imaging technologies. Notably, CRISPR/Cas systems have emerged as a revolutionary genome-editing platform, offering unprecedented opportunities for manipulating 3D genome organization and investigating disease mechanisms. This review systematically examines recent advances in CRISPR-based mammalian 3D genome engineering and explores the therapeutic potential of 3D genome engineering strategies in disease intervention.

摘要

动态染色质三维(3D)构象是发育和疾病过程中调节基因表达和细胞功能的关键机制。阐明3D基因组的结构、功能动力学和时空组织需要整合多种实验方法,包括染色质构象捕获技术、精确的基因组操作工具和先进的成像技术。值得注意的是,CRISPR/Cas系统已成为一个革命性的基因组编辑平台,为操纵3D基因组组织和研究疾病机制提供了前所未有的机会。本文综述系统地研究了基于CRISPR的哺乳动物3D基因组工程的最新进展,并探讨了3D基因组工程策略在疾病干预中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/47020fa42472/research.0865.fig.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/a7995860ac2b/research.0865.fig.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/3cb7dbed1ed4/research.0865.fig.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/1cd28ca42e70/research.0865.fig.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/4b7b7c08dcd1/research.0865.fig.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/d5cd53182927/research.0865.fig.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/47020fa42472/research.0865.fig.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/a7995860ac2b/research.0865.fig.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/3cb7dbed1ed4/research.0865.fig.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/1cd28ca42e70/research.0865.fig.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/4b7b7c08dcd1/research.0865.fig.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/d5cd53182927/research.0865.fig.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0af/12399806/47020fa42472/research.0865.fig.006.jpg

相似文献

1
3D Genome Engineering: Current Advances and Therapeutic Opportunities in Human Diseases.3D基因组工程:人类疾病的当前进展与治疗机遇
Research (Wash D C). 2025 Sep 1;8:0865. doi: 10.34133/research.0865. eCollection 2025.
2
Unlocking the potential of CRISPR-Cas9 for cystic fibrosis: A systematic literature review.挖掘CRISPR-Cas9治疗囊性纤维化的潜力:一项系统文献综述
Gene. 2025 Mar 20;942:149257. doi: 10.1016/j.gene.2025.149257. Epub 2025 Jan 18.
3
Off-target interactions in the CRISPR-Cas9 Machinery: mechanisms and outcomes.CRISPR-Cas9机制中的脱靶相互作用:机制与结果
Biochem Biophys Rep. 2025 Jul 5;43:102134. doi: 10.1016/j.bbrep.2025.102134. eCollection 2025 Sep.
4
CRISPR/Cas genome editing in soybean: challenges and new insights to overcome existing bottlenecks.大豆中的CRISPR/Cas基因组编辑:克服现有瓶颈的挑战与新见解
J Adv Res. 2024 Aug 18. doi: 10.1016/j.jare.2024.08.024.
5
Engineered Bacteriophages: Advances in Phage Genome Redesign Strategies for Therapeutic and Environmental Applications.工程噬菌体:用于治疗和环境应用的噬菌体基因组重新设计策略的进展
Protein Pept Lett. 2025 Jul 2. doi: 10.2174/0109298665372719250616085616.
6
CRISPR/Cas9-mediated genome editing in Ganoderma lucidum: recent advances and biotechnological opportunities.CRISPR/Cas9介导的灵芝基因组编辑:最新进展与生物技术机遇
World J Microbiol Biotechnol. 2025 Jun 25;41(7):223. doi: 10.1007/s11274-025-04458-9.
7
Transferable approaches to CRISPR-Cas9 induced genome editing in non-model insects: a brief guide.非模式昆虫中CRISPR-Cas9介导的基因组编辑的可转移方法:简要指南
Front Zool. 2025 Jul 7;22(1):13. doi: 10.1186/s12983-025-00566-2.
8
Innovative approaches to combat antibiotic resistance: integrating CRISPR/Cas9 and nanoparticles against biofilm-driven infections.对抗抗生素耐药性的创新方法:整合CRISPR/Cas9和纳米颗粒以对抗生物膜驱动的感染。
BMC Med. 2025 Aug 20;23(1):486. doi: 10.1186/s12916-025-04323-4.
9
CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics.CRISPR/Cas生物成像:从全身生物分布到单细胞动态变化
Adv Drug Deliv Rev. 2025 Sep;224:115619. doi: 10.1016/j.addr.2025.115619. Epub 2025 May 29.
10
Unravelling fungal genome editing revolution: pathological and biotechnological application aspects.解析真菌基因组编辑革命:病理学与生物技术应用方面
Arch Microbiol. 2025 May 22;207(7):150. doi: 10.1007/s00203-025-04360-w.

本文引用的文献

1
CTCF depletion decouples enhancer-mediated gene activation from chromatin hub formation.CTCF缺失使增强子介导的基因激活与染色质枢纽形成解偶联。
Nat Struct Mol Biol. 2025 May 13. doi: 10.1038/s41594-025-01555-z.
2
FISHnet: detecting chromatin domains in single-cell sequential Oligopaints imaging data.FISHnet:在单细胞序列寡核苷酸荧光原位杂交成像数据中检测染色质结构域
Nat Methods. 2025 May 12. doi: 10.1038/s41592-025-02688-1.
3
High-resolution dynamic imaging of chromatin DNA communication using Oligo-LiveFISH.使用寡核苷酸实时荧光原位杂交技术对染色质与DNA相互作用进行高分辨率动态成像
Cell. 2025 Jun 12;188(12):3310-3328.e27. doi: 10.1016/j.cell.2025.03.032. Epub 2025 Apr 15.
4
Perturb-tracing enables high-content screening of multi-scale 3D genome regulators.扰动追踪能够对多尺度3D基因组调控因子进行高内涵筛选。
Nat Methods. 2025 May;22(5):950-961. doi: 10.1038/s41592-025-02652-z. Epub 2025 Apr 10.
5
Binding domain mutations provide insight into CTCF's relationship with chromatin and its contribution to gene regulation.结合结构域突变有助于深入了解CTCF与染色质的关系及其对基因调控的作用。
Cell Genom. 2025 Apr 9;5(4):100813. doi: 10.1016/j.xgen.2025.100813. Epub 2025 Mar 20.
6
CTCF is selectively required for maintaining chromatin accessibility and gene expression in human erythropoiesis.CTCF对于维持人类红细胞生成过程中的染色质可及性和基因表达具有选择性需求。
Genome Biol. 2025 Feb 28;26(1):44. doi: 10.1186/s13059-025-03510-z.
7
A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels.一种靶向人类前蛋白转化酶枯草溶菌素9(PCSK9)的强效表观遗传编辑器,用于持久降低低密度脂蛋白胆固醇水平。
Nat Med. 2025 Apr;31(4):1329-1338. doi: 10.1038/s41591-025-03508-x. Epub 2025 Feb 10.
8
Long-read genome sequencing resolves complex genomic rearrangements in rare genetic syndromes.长读长基因组测序可解析罕见遗传综合征中的复杂基因组重排。
NPJ Genom Med. 2024 Dec 18;9(1):66. doi: 10.1038/s41525-024-00454-4.
9
CTCF Point Mutation at R567 Disrupts Mouse Heart Development via 3D Genome Rearrangement and Transcription Dysregulation.R567位点的CTCF点突变通过三维基因组重排和转录失调破坏小鼠心脏发育。
Cell Prolif. 2025 Apr;58(4):e13783. doi: 10.1111/cpr.13783. Epub 2024 Dec 16.
10
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.维奈托克联合阿扎胞苷用于初治高危骨髓增生异常综合征患者的疗效和安全性
Blood. 2025 Mar 13;145(11):1126-1135. doi: 10.1182/blood.2024025464.